Gastrointestinal Therapeutics Market Insights: Forecasted to Hit US$ 78.58 Bn by 2030 with a 5.59% CAGR

No comments

Anticipated Growth in Revenue:

Gastrointestinal Therapeutics Market size is expected to reach US$ 78.58 Bn. by 2030, at a CAGR of 5.59% during the forecast period. The report has covered Country Market trends with competitive landscape.

Gastrointestinal Therapeutics Market Overview:

The Global Gastrointestinal Therapeutics Market is poised for substantial growth, projected to reach US$ 78.58 billion by 2030, with a CAGR of 5.59% during the forecast period. This growth is largely attributed to the increasing prevalence of gastrointestinal disorders and the rising adoption of innovative biologic therapies. With the growing acceptance of biologics such as tofacitinib and vedolizumab, along with established drugs like Humira and Remicade, the market is set for a transformative phase. Biologics have shown remarkable long-term efficacy in managing conditions like ulcerative colitis and Crohn’s disease, significantly reducing hospitalizations and surgeries.

Get in touch with an analyst to personalize your report:https://www.maximizemarketresearch.com/request-sample/38877/

Gastrointestinal Therapeutics Market Scope:

This report provides a comprehensive analysis of the Gastrointestinal Therapeutics Market, focusing on the key stakeholders, current market trends, and future forecasts. It covers various aspects, including the competitive landscape, market dynamics, and segment analysis, ensuring a detailed understanding for decision-makers. Additionally, the report evaluates the market using analytical frameworks like Porter’s Five Forces, SWOT, and PESTLE analysis, providing insights into both external and internal factors influencing the market.

Gastrointestinal Therapeutics Market Drivers:

Several factors are driving the growth of the gastrointestinal therapeutics market:

Other Post You May Be Interested In

  1. Rising Adoption of Biologics: The shift towards biologics in treating gastrointestinal diseases is a key driver. These therapies have demonstrated superior long-term efficiency, resulting in significant reductions in surgeries, hospital stays, and the overall burden of disease.
  2. Technological Advancements: Continuous research and development in targeted therapies and biologics are propelling market growth. FDA-approved drugs like Amjevita, Cimzia, and Entyvio pave the way for future innovations in treatment.
  3. Growing Generic Market: The expiration of patents on established drugs has led to an influx of generic medications. These alternatives are often more affordable, making treatment more accessible to a broader population.
  4. Increasing Incidence of Gastrointestinal Disorders: Changing lifestyles and dietary habits have contributed to a rise in gastrointestinal disorders, boosting demand for therapeutic solutions.

Gastrointestinal Therapeutics Market Segmentation:

by Type

Branded
Generics

by Route of Administration

Oral
Intravenous
Others

by Application

Ulcerative Colitis
Crohn’s Disease
GERD
Others

by Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Gastrointestinal Therapeutics Market Key Players: The key players are

1. Abbott Laboratories – Abbott Park, Illinois, United States
2. AstraZeneca – Cambridge, England
3. Bayer AG – Leverkusen, Germany
4. Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) – Beerse, Belgium
5. Takeda Pharmaceuticals – Tokyo, Japan
6. Pfizer – New York City, New York, United States
7. AbbVie Inc. – North Chicago, Illinois, United States
8. Valeant (Salix Pharmaceuticals) – Bridgewater, New Jersey, United States
9. Takeda Pharmaceutical Company Limited – Tokyo, Japan
10. Eisai Co. Ltd. – Tokyo, Japan
11. Johnson & Johnson Private Limited – Mumbai, India
12. Astellas Pharma Inc. – Tokyo, Japan
13. Sanofi S.A. – Paris, France
14. Bausch Health Companies Inc – Laval, Quebec, Canada
15. Cipla – Mumbai, India
16. Pfizer Inc. – New York City, New York, United States
17. Bayer AG – Leverkusen, Germany
18. Biogen – Cambridge, Massachusetts, United States
19. Azurity Pharmaceuticals, Inc. – Wilmington, Massachusetts, United States
20. Iterative Health – Boston, Massachusetts, United States

If You Have Any Questions About This Report? Please Contact Us On the link mentioned below:

Gastrointestinal Therapeutics Market Regional Analysis:

The North America region dominated the gastrointestinal therapeutics market in 2023, driven by a combination of lifestyle changes and robust healthcare initiatives. The increasing incidence of gastrointestinal diseases in this region, along with government-supported programs like the Integrated Global Action Plan for Diarrhoea, significantly contributes to market growth.

In addition, recent drug approvals, including AbbVie Inc.’s RINVOQ and BMS’s Zeposia, are expected to further enhance market penetration and adoption rates. Other regions, particularly Europe and Asia-Pacific, are also witnessing growth due to the increasing availability of advanced therapeutic options and a growing awareness of gastrointestinal disorders.

COVID-19 Impact Analysis on Gastrointestinal Therapeutics Market:

The COVID-19 pandemic had a complex impact on the gastrointestinal therapeutics market. While healthcare systems faced unprecedented challenges, the pandemic highlighted the importance of effective management of chronic conditions, including gastrointestinal disorders. The shift towards telemedicine during the pandemic provided an alternative for patients, ensuring continued access to care.

Moreover, the crisis accelerated the research and development of biologics and therapeutic solutions as the demand for effective treatment increased. However, supply chain disruptions and the temporary suspension of non-essential healthcare services posed challenges to the market during the peak of the pandemic. As healthcare systems stabilize, the market is expected to rebound and continue its growth trajectory.

Key Questions Answered in the Gastrointestinal Therapeutics Market Report are:

  • What will be the CAGR of the Gastrointestinal Therapeutics market during the forecast period?
  • Which segment emerged as the leading segment in the Gastrointestinal Therapeutics market?
  • Which are the prominent players in the Gastrointestinal Therapeutics market?

Browse Our Top Trending Reports:

Global Night Vision Surveillance Cameras Market

Global Mobile BI Market

Global Reciprocating Compressor Market

About Maximize Market Research:

Maximize Market Research is a rapidly expanding market research and business consulting firm with a global client base. Our revenue impact and growth-focused research initiatives have established us as a trusted partner for many Fortune 500 companies. We boast a diversified portfolio, serving a wide range of industries including IT & telecom, chemicals, food & beverage, aerospace & defense, healthcare, and more.

Contact Maximize Market Research:

MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
✆ +91 9607365656
🖂 sales@maximizemarketresearch.com
🌐 www.maximizemarketresearch.com

SHARE NOW
Tagged with , , , , , , , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *